Clinical Trial Update: Efficacy and Safety of Lemborexant for Patients With Cirrhosis and Sleep Problems [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of lemborexant for sleep problems in patients with liver cirrhosis; the study status is completed, with no resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy
• Insomnia
• Liver Cirrhosis

Drugs mentioned

• Dayvigo (lemborexant)

Snippet

Sponsor: Indonesia University | Conditions: Cirrhosis, Liver Cirrhosis | Phase 2 | Status: COMPLETED